Partially Reversible Immunodeficiency After In-Utero Exposure to Immunosuppressants

Dtsch Arztebl Int. 2023 Nov 17;120(46):795-796. doi: 10.3238/arztebl.m2023.0200.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Immunologic Deficiency Syndromes* / chemically induced
  • Immunosuppressive Agents* / adverse effects
  • Prenatal Exposure Delayed Effects*

Substances

  • Immunosuppressive Agents